MP13-15 68GA-PSMA-11 PET/MPMRI FOR DETECTION OF PRIMARY PROSTATE CANCER IN PREVIOUSLY NEGATIVE-BIOPSIED MEN

@article{Gesterkamp2020MP13156P,
  title={MP13-15 68GA-PSMA-11 PET/MPMRI FOR DETECTION OF PRIMARY PROSTATE CANCER IN PREVIOUSLY NEGATIVE-BIOPSIED MEN},
  author={Hannah Gesterkamp and Kay Westenfelder and J{\"u}rgen Gschwend and Wolfgang Andreas Weber and Isabel Rauscher and Lars Budaeus and Matthias Eiber and Tobias Maurer},
  journal={Journal of Urology},
  year={2020}
}
radiotracer uptake values correlate with disease severity. METHODS: Patients with biopsy proven intermediate to high risk primary prostate cancer received 68Ga-PSMA PET/CT as part of standard clinical care for disease staging, followed by 68Ga-PSMA PET/MRI later the same day. Whole-mount histopathological analysis was performed on radical prostatectomy specimens, allowing for precise lesion localisation on a custom made 12-sector prostate map. ‘Positive' lesions were defined as Grade Group 2…